Johns Hopkins researchers design ‘prodrug’ that targets cancer cells’ big appetite for glutamine, leaving healthy cells unharmed
Johns Hopkins Medicine researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed. Scientists have dubbed this type of...















